MedPath

A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Oxycontine CR 10mg
Drug: GL2907
Registration Number
NCT01779492
Lead Sponsor
GL Pharm Tech Corporation
Brief Summary

The purpose of this clinical trial is to compare the pharmacokinetic characteristics of GL2907 XL 20mg tablet and Oxycontin CR 10mg tablet.

Detailed Description

GL2907 XL 20mg tablet is controlled released formulation which is made by GL Pharm Tech.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
24
Inclusion Criteria
  • 20~45 years old, Healthy Adult Male Subject
  • Body Weight ≥ 50kg and Ideal Body Weight ≤ ±20%
Exclusion Criteria
  • ALT or AST > 1.25 times (Upper Normal Range)
  • Total Bilirubin > 1.5 times (Upper Normal Range)
  • CPK > 2 times (Upper Normal Range)
  • BUN or Creatinine > Normal Range
  • Systolic BP > 160mmHg or < 80mmHg, Diastolic BP > 100mmHg or < 50mmHg

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Oxycontine CR 10mgOxycontine CR 10mgOxycodone HCl 10mg
GL2907GL2907Oxycodone HCl 20mg
Primary Outcome Measures
NameTimeMethod
Cmax,ss48h

Pharmacokinetic of Oxycodone

AUCτ24h

Pharmacokinetic of Oxycodone

Secondary Outcome Measures
NameTimeMethod
t1/248h

Pharmacokinetic of Oxycodone

Vz/f48h

Pharmacokinetic of Oxycodone

CL/F48h

Pharmacokinetic of Oxycodone

Tmax48h

Pharmacokinetic of Oxycodone

degree og fluctuation48h

Pharmacokinetic of Oxycodone

(Cmax,ss-Cmin,ss)/Cave,ss

swing48h

Pharmacokinetic of Oxycodone

(Cmax,ss-Cmin,ss)/Cmin,ss

R48h

Pharmacokinetic of Oxycodone

Accumulation index

Cmin,ss48h

Pharmacokinetic of Oxycodone

Cave,ss48h

Pharmacokinetic of Oxycodone

Trial Locations

Locations (1)

AJOU University Hospital

🇰🇷

Suwon, Gyeonggido, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath